The proposal would change how Americans recovering from addiction can get the opioid-substitute medicine used to stop cravings, withdrawal symptoms.
Author: Ken Alltucker, USA TODAY
Cease-fire in Sudan extended three days, Secretary of State Antony Blinken says: Live updates
The U.S. has deployed intelligence, surveillance and reconnaissance assets to aid people traveling by land from Khartoum to the Port of Sudan.
As states cut Medicaid, some fear they’ll mistakenly end coverage for millions of eligible people
States are resuming Medicaid eligibility checks that were paused during the COVID public health emergency.
A billing dispute means a mom must pay nearly $1,000 a month for her son’s diabetes care
A New York family’s struggle to get care is an example of how difficult it can be for people to afford the cost of medical care needed for diabetes.
3 major insulin makers have now slashed the price of the life-saving drug. Here’s why.
Sanofi on Thursday became the last major insulin maker to cut the price of the life-saving drug. Here’s why it’s been so expensive and what’s next.
Eli Lilly to cut insulin prices up to 70% amid federal pressure to lower costs
Drugmaker Eli Lilly says it will cut its insulin prices up to 70% and cap out-of-pocket costs for privately insured consumers at $35 a month.
US nursing homes aren’t safe amid climate crisis, report finds. And it’s getting worse.
A Senate committee report highlights the risks seniors and disabled residents face during extreme heat or cold, floods, tornadoes or wildfires.
3 teen girls killed in apparent murder-suicide in Texas; 12-year-old escapes after assault
Three teenage girls, including one who was pregnant, were fatally shot Saturday night by man who then killed himself in an apparent murder-suicide.
One dead, 10 injured in Memphis shooting; 3 people of interest sought
One person died and 10 were injured early Sunday after gunfire erupted at the Live Lounge nightclub in Memphis, police said.
First it was blood pressure medication. Now FDA eyes more drugs for cancer-causing chemical.
Here’s what the FDA is doing to protect consumers after drugs such as quinapril, Zantac and Metformin were recalled over chemicals linked to cancer.